View in EDS

Zirconium doped hydroxyapatite nanoparticle as a potential design for lung cancer therapy.

Saved in:
Bibliographic Details
Title: Zirconium doped hydroxyapatite nanoparticle as a potential design for lung cancer therapy.
Authors: Febrian, Muhamad Basit1 (AUTHOR) mbasitf@batan.go.id, Mahendra, Isa1 (AUTHOR), Kurniawan, Ahmad1 (AUTHOR), Setiadi, Yanuar1 (AUTHOR), Ambar Wibawa, Teguh Hafiz1 (AUTHOR), Lesmana, Ronny2 (AUTHOR), Syarif, Dani Gustaman1 (AUTHOR) danigus@batan.go.id
Source: Ceramics International. Oct2021, Vol. 47 Issue 19, p27890-27897. 8p.
Subjects: Lung cancer, Cancer treatment, Zirconium, Causes of death, Hydroxyapatite, Radiation dosimetry, Magnetic nanoparticle hyperthermia, Nanocarriers
Abstract: Lung cancer is the most common type of cancer, being the leading cause of death worldwide. Several efforts for the prevention and treatment have been made to suppress the growth of lung cancer. In this context, hydroxyapatite (HAp) nanoparticles have potential to induce apoptosis in cancer cells and, therefore, can be used for the treatment of cancer. The combination of HAp nanoparticles with a drug loader such as zirconium (Zr) is expected to improve the efficacy of HAp nanoparticles in lung cancer treatment. In this study, Zr doped hydroxyapatite (HAp-Zr) nanoparticles were designed for lung cancer therapy. HAp-Zr nanoparticles were prepared by doping the HAp nanoparticles with Zr. The cytotoxic assay to the cancer cell of HAp-Zr nanoparticles was determined in the lung cancer cell line A549. The nanoparticles were labeled using Scandium-46 radioisotope ([46Sc]Sc-HAp-Zr) to evaluate the cellular uptake and biodistribution studies. The results showed that the [46Sc]Sc-HAp-Zr nanoparticles were accumulated in the lung cancer cell line A549, and Zr doped increased the cellular internalization. The cytotoxic assay showed that the IC 50 value of the HAp-Zr nanoparticles was 513 μg/mL. In the biodistribution studies on normal mice, the radiolabeled [46Sc]Sc-HAp-Zr showed a high accumulation in the liver as an excreted organ and in the lungs as the target organ. Taken together, these findings suggest that HAp-Zr nanoparticles have the potential to be used as drug candidate for the treatment of lung cancer. [ABSTRACT FROM AUTHOR]
Copyright of Ceramics International is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Engineering Source
FullText Text:
  Availability: 0
Header DbId: egs
DbLabel: Engineering Source
An: 152063651
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Zirconium doped hydroxyapatite nanoparticle as a potential design for lung cancer therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Febrian%2C+Muhamad+Basit%22">Febrian, Muhamad Basit</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> mbasitf@batan.go.id</i><br /><searchLink fieldCode="AR" term="%22Mahendra%2C+Isa%22">Mahendra, Isa</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kurniawan%2C+Ahmad%22">Kurniawan, Ahmad</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Setiadi%2C+Yanuar%22">Setiadi, Yanuar</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ambar+Wibawa%2C+Teguh+Hafiz%22">Ambar Wibawa, Teguh Hafiz</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lesmana%2C+Ronny%22">Lesmana, Ronny</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Syarif%2C+Dani+Gustaman%22">Syarif, Dani Gustaman</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> danigus@batan.go.id</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Ceramics+International%22">Ceramics International</searchLink>. Oct2021, Vol. 47 Issue 19, p27890-27897. 8p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Lung+cancer%22">Lung cancer</searchLink><br /><searchLink fieldCode="DE" term="%22Cancer+treatment%22">Cancer treatment</searchLink><br /><searchLink fieldCode="DE" term="%22Zirconium%22">Zirconium</searchLink><br /><searchLink fieldCode="DE" term="%22Causes+of+death%22">Causes of death</searchLink><br /><searchLink fieldCode="DE" term="%22Hydroxyapatite%22">Hydroxyapatite</searchLink><br /><searchLink fieldCode="DE" term="%22Radiation+dosimetry%22">Radiation dosimetry</searchLink><br /><searchLink fieldCode="DE" term="%22Magnetic+nanoparticle+hyperthermia%22">Magnetic nanoparticle hyperthermia</searchLink><br /><searchLink fieldCode="DE" term="%22Nanocarriers%22">Nanocarriers</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Lung cancer is the most common type of cancer, being the leading cause of death worldwide. Several efforts for the prevention and treatment have been made to suppress the growth of lung cancer. In this context, hydroxyapatite (HAp) nanoparticles have potential to induce apoptosis in cancer cells and, therefore, can be used for the treatment of cancer. The combination of HAp nanoparticles with a drug loader such as zirconium (Zr) is expected to improve the efficacy of HAp nanoparticles in lung cancer treatment. In this study, Zr doped hydroxyapatite (HAp-Zr) nanoparticles were designed for lung cancer therapy. HAp-Zr nanoparticles were prepared by doping the HAp nanoparticles with Zr. The cytotoxic assay to the cancer cell of HAp-Zr nanoparticles was determined in the lung cancer cell line A549. The nanoparticles were labeled using Scandium-46 radioisotope ([46Sc]Sc-HAp-Zr) to evaluate the cellular uptake and biodistribution studies. The results showed that the [46Sc]Sc-HAp-Zr nanoparticles were accumulated in the lung cancer cell line A549, and Zr doped increased the cellular internalization. The cytotoxic assay showed that the IC 50 value of the HAp-Zr nanoparticles was 513 μg/mL. In the biodistribution studies on normal mice, the radiolabeled [46Sc]Sc-HAp-Zr showed a high accumulation in the liver as an excreted organ and in the lungs as the target organ. Taken together, these findings suggest that HAp-Zr nanoparticles have the potential to be used as drug candidate for the treatment of lung cancer. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Ceramics International is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=egs&AN=152063651
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ceramint.2021.06.219
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 8
        StartPage: 27890
    Subjects:
      – SubjectFull: Lung cancer
        Type: general
      – SubjectFull: Cancer treatment
        Type: general
      – SubjectFull: Zirconium
        Type: general
      – SubjectFull: Causes of death
        Type: general
      – SubjectFull: Hydroxyapatite
        Type: general
      – SubjectFull: Radiation dosimetry
        Type: general
      – SubjectFull: Magnetic nanoparticle hyperthermia
        Type: general
      – SubjectFull: Nanocarriers
        Type: general
    Titles:
      – TitleFull: Zirconium doped hydroxyapatite nanoparticle as a potential design for lung cancer therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Febrian, Muhamad Basit
      – PersonEntity:
          Name:
            NameFull: Mahendra, Isa
      – PersonEntity:
          Name:
            NameFull: Kurniawan, Ahmad
      – PersonEntity:
          Name:
            NameFull: Setiadi, Yanuar
      – PersonEntity:
          Name:
            NameFull: Ambar Wibawa, Teguh Hafiz
      – PersonEntity:
          Name:
            NameFull: Lesmana, Ronny
      – PersonEntity:
          Name:
            NameFull: Syarif, Dani Gustaman
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: Oct2021
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-print
              Value: 02728842
          Numbering:
            – Type: volume
              Value: 47
            – Type: issue
              Value: 19
          Titles:
            – TitleFull: Ceramics International
              Type: main
ResultId 1